Torsemide: Advanced Loop Diuretic for Effective Fluid Management
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.43 | $38.70 (0%) | 🛒 Add to cart |
| 120 | $0.39 | $51.60 $46.44 (10%) | 🛒 Add to cart |
| 180 | $0.33 | $77.40 $60.20 (22%) | 🛒 Add to cart |
| 270 | $0.31 | $116.10 $83.42 (28%) | 🛒 Add to cart |
| 360 | $0.29
Best per pill | $154.80 $104.06 (33%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.76 | $45.58 (0%) | 🛒 Add to cart |
| 90 | $0.69 | $68.37 $61.92 (9%) | 🛒 Add to cart |
| 120 | $0.65 | $91.16 $78.26 (14%) | 🛒 Add to cart |
| 180 | $0.62 | $136.74 $110.94 (19%) | 🛒 Add to cart |
| 270 | $0.59 | $205.11 $159.10 (22%) | 🛒 Add to cart |
| 360 | $0.58
Best per pill | $273.48 $208.12 (24%) | 🛒 Add to cart |
Synonyms | |||
Torsemide is a potent loop diuretic indicated for the management of edema associated with congestive heart failure, renal disease, and hepatic cirrhosis. It functions by inhibiting sodium and chloride reabsorption in the thick ascending limb of the loop of Henle, leading to a significant increase in urine output (diuresis). Clinically, it is valued for its predictable pharmacokinetics, including high bioavailability and a longer duration of action compared to some other agents in its class. Its use is supported by extensive clinical evidence in both acute and chronic settings, making it a cornerstone therapy in volume overload conditions.
Features
- Active ingredient: Torsemide
- Drug class: Loop diuretic
- Available strengths: 5 mg, 10 mg, 20 mg, 100 mg tablets
- Bioavailability: Approximately 80%
- Onset of action: Within 1 hour (oral)
- Peak effect: 1–2 hours
- Duration of action: 6–8 hours
- Metabolism: Hepatic (CYP2C9)
- Excretion: Primarily renal (80%), fecal (20%)
- Half-life: 3.5 hours
Benefits
- Rapid and effective reduction of edema and fluid overload in congestive heart failure, cirrhosis, and renal impairment
- Predictable dose-response relationship allowing for tailored therapeutic regimens
- Lower risk of ototoxicity compared to furosemide in some patient populations
- Once-daily dosing convenience in many cases, supporting adherence
- Demonstrated efficacy in reducing hospitalizations for heart failure exacerbations
- May offer improved potassium-sparing effects relative to other loop diuretics when used appropriately
Common use
Torsemide is commonly prescribed for the treatment of edema due to congestive heart failure, chronic kidney disease, and hepatic cirrhosis. It is also used in the management of hypertension, either as monotherapy or in combination with other antihypertensive agents. In clinical practice, it is often selected for patients who exhibit suboptimal response or adverse effects to other diuretics, such as furosemide. Its reliable absorption and consistent effect make it suitable for both outpatient and inpatient settings.
Dosage and direction
Dosage must be individualized based on patient response, underlying condition, and renal function. For edema in congestive heart failure or renal disease: initial dose is typically 10–20 mg once daily, which may be increased gradually. For hepatic cirrhosis: start with 5–10 mg once daily, administered together with an aldosterone antagonist or potassium-sparing diuretic. For hypertension: usual starting dose is 5 mg once daily, which may be increased to 10 mg after 4–6 weeks if needed. Tablets should be taken orally, with or without food. Monitoring of electrolytes and renal function is recommended during therapy.
Precautions
Patients should be monitored for signs of electrolyte imbalance (hypokalemia, hyponatremia, hypochloremic alkalosis), especially during initial therapy or after dose adjustments. Use with caution in patients with sulfonamide allergy, although cross-reactivity is rare. Hepatic impairment may alter drug metabolism; dose adjustment may be necessary. Avoid rapid diuresis to prevent precipitous changes in fluid and electrolyte balance. Orthostatic hypotension may occur; advise patients to rise slowly from sitting or lying positions. Not recommended during pregnancy unless potential benefit justifies potential risk.
Contraindications
Torsemide is contraindicated in patients with known hypersensitivity to torsemide or any component of the formulation. It is also contraindicated in anuria and in patients with hepatic coma or severe electrolyte depletion until the condition is improved or corrected. Avoid use in patients with documented sulfonamide allergy, although the risk of cross-sensitivity is lower than with thiazide diuretics.
Possible side effect
Common side effects include dizziness, headache, excessive urination, hyperglycemia, and hyperuricemia. Less frequently, orthostatic hypotension, electrolyte disturbances (hypokalemia, hyponatremia, hypomagnesemia), and increases in blood urea nitrogen (BUN) and creatinine may occur. Rare but serious adverse effects include ototoxicity (especially with rapid IV administration or concurrent use of other ototoxic drugs), Stevens-Johnson syndrome, and pancreatitis. Patients should report signs of allergy, hearing changes, or severe gastrointestinal symptoms.
Drug interaction
Torsemide may interact with several drug classes. NSAIDs may reduce its diuretic and antihypertensive effects. Concomitant use with other antihypertensives may potentiate hypotension. It may enhance the nephrotoxic potential of aminoglycosides and the ototoxic effects of other loop diuretics or platinum-based chemotherapy. Corticosteroids and amphotericin B may increase the risk of hypokalemia. Lithium levels may increase due to reduced renal clearance. Probenecid may reduce torsemide’s diuretic effect. Monitor closely when used with digoxin due to risk of hypokalemia-induced toxicity.
Missed dose
If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the usual dosing schedule. Do not double the dose to make up for a missed one. Consistent daily dosing is important for maintaining therapeutic effect, particularly in hypertension management.
Overdose
Overdose may lead to profound diuresis with water and electrolyte depletion, manifesting as dehydration, hypotension, tachycardia, and electrolyte abnormalities such as hypokalemia or hyponatremia. Treatment is supportive and includes cessation of torsemide, fluid and electrolyte replacement, and monitoring of vital signs and renal function. Hemodialysis is not effective due to high protein binding. Symptomatic management of complications such as arrhythmias or shock may be necessary.
Storage
Store at controlled room temperature, 20–25°C (68–77°F), in a dry place protected from light and moisture. Keep in the original container with the lid tightly closed. Do not use after the expiration date printed on the packaging. Keep out of reach of children and pets.
Disclaimer
This information is intended for educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Do not disregard professional medical advice or delay in seeking it because of something you have read here. Dosage and indications may vary based on individual patient factors and regional prescribing guidelines.
Reviews
Torsemide is generally well-regarded in the medical community for its efficacy and predictable pharmacokinetic profile. Clinical studies, such as those in heart failure populations, have demonstrated its superiority in some endpoints compared to furosemide, including reduced hospitalization rates. Practitioners appreciate its once-daily dosing in many scenarios and its reliable absorption. Some note the need for careful electrolyte monitoring, especially in elderly or renally impaired patients. Overall, it is considered a valuable tool in the management of volume overload states.